Session » Sjögren's Syndrome II: Pathogenesis, Autoantibodies and T-Cells
-
Abstract Number: 2872
Elevated mTORC1 Signature in B Cells from Sjögren’s Syndrome Patients: mTOR Inhibition As a Novel Therapeutic Strategy to Halt B Cell Hyperactivity
-
Abstract Number: 2873
DNA Microarray Analysis Identifies Nuclear Receptor Subfamily 4 Group a Member 2 (NR4A2) As a Novel Molecule Involved in the Pathogenesis of Sjogren’s Syndrome
-
Abstract Number: 2874
Thymic Stromal Lymphopoietin (TSLP) Expression Is Associated with Lymphoproliferation and Lymphoma in Primary Sjögren’s Syndrome
-
Abstract Number: 2875
Molecular Features Define Unique Sjögren’s Syndrome Patient Subsets
-
Abstract Number: 2876
Analysis of Autoantibody Reactivity to the Complete Human Peptidome By Phage Immunoprecipitation Sequencing Does Not Identify a Predominant Novel Autoantibody in Sjogren’s Syndrome
-
Abstract Number: 2877
Premature Senescence of Naive CD4+ T-Cells in Primary Sjogren’s Syndrome